Coevolution shapes interorganismal crosstalk leading to profound and diverse cellular and metabolic changes as observed in gut dysbiosis in human diseases. Here, we modulated a simplified gut microbiota using pro-, pre-, and synbiotics to assess the depth of systemic metabolic exchanges in mice, using a multicompartmental modeling approach with metabolic signatures from 10 tissue/fluid compartments. The nutritionally induced microbial changes modulated host lipid, carbohydrate, and amino acid metabolism at a panorganismal scale. Galactosyl-oligosaccharides reduced lipogenesis, triacylglycerol incorporation into lipoproteins and triglyceride concentration in the liver and the kidney. Those changes were not correlated with decreased plasma lipoproteins that were specifically induced by L. rhamnosus supplementation. Additional alteration of transmethylation metabolic pathways (homocysteine-betaine) was observed in the liver and the pancreas following pre-and synbiotic microbial modulation, which may be of interest for control of glucose metabolism and insulin sensitivity. Probiotics also reduced hepatic glycogen and glutamine and adrenal ascorbate with inferred effects on energy homeostasis, antioxidation, and steroidogenesis. These studies show the breadth and the depth of gut microbiome modulations of host biochemistry and reveal that major mammalian metabolic processes are under symbiotic homeostatic control.
Introduction
All coelomate vertebrates and invertebrates have coevolved with symbiotic gut microbes that perform multiple digestive and metabolic functions 1 for the host, and this has resulted in the ability of organisms to engage in enhanced adaptive radiation to exploit new dietary resources. In man, dietary preferences, lifestyle and genetics influence microbial population and ecological development, and these interactions determine the health of both individuals and populations. 2, 3 Perhaps one of the greatest challenges in modern biology is to interrogate and classify these critical transgenomic interactions and to understand their role in diverse human disease processes.
The consortium of symbiotic gut microorganisms (the microbiome) can be viewed as a metabolically adaptable, rapidly renewable and metabolically flexible virtual "organ". 4 It is well established that the gut microbiota plays an essential role in the development and homeostasis of the mucosal innate and adaptive immune system. 5 The maintenance of physiological equilibrium at the mucosal interface, on which both host and gut microbiota exert reciprocal control, is indeed determinant for metabolic health. Maybe not surprising, the nature of the gut microbiome-host interactions seems such that the host controls the microbiome community structure, a process that has evolved to attain specific benefits ranging from protection to nutrition to physiology. 6 Besides direct control over the microbiota by the host, nutrition helps to shape the microbiota from birth onward. The gastrointestinal tract of a normal fetus is sterile in utero and is rapidly colonized with microbes from the mother at birth and subsequently from the surrounding environment, developing into a dense and complex microbial community. 7 Marked differences in gut microbiota composition of formula-fed and breast-fed neonates have been observed, and the nutritional composition of breast-milk as compared to formula milk is believed to be a key determinant to this end. Moreover, breastfeeding is associated with a lower incidence of infections, morbidity and mortality as compared to formula feeding, 8 and in part, this is thought to be due to the elevated bifidobacteria counts and the higher intestinal acidity 9 in breastfed infants.
The acquired gut microbiota has subsequently profound effects on the determination of host nutrition, physiology, immunology and protective functions. 5, 10, 11 Increasingly, health disorders related to uncontrolled immune reactions and disequilibrated sugar and lipid metabolism are associated with changed gut microbiome community structures. 3, 11, 12 As the gut microbiota interacts strongly with the host and the ingested nutrients to determine immune and metabolic health as well as nutritional status, there is clearly an important role of understanding these interactions as part of optimized nutrition. Nutrimetabonomics provides a systems approach to assess systemic metabolic status of an individual, which encapsulates information on genetic and environmental factors, gut microbiota activity, lifestyle, and food habits. 2 These techniques have been used to decipher gut microbial-mammalian cometabolic processes linking host and symbiont physiology [13] [14] [15] and to assess the impact of nutritional interventions on microbialmammalian cometabolism. 16, 17 In particular, we reported that inoculating germfree mice with a model of human baby microbiota (HBM) was a well-adapted model to assess the impact of nutritional intervention on mammalian gut microbial metabolic interactions. 13 In addition, our results also demonstrated the limitations of the model in that HBM was not optimal for murine hosts because it drove the metabolism toward a prepathological state. 13 Recently, we assessed the metabolic effects of L. rhamnosus probiotics and synbiotic supplementation with galactosyloligosaccharides on host system metabolism through the analysis of systemic biofluids and liver in gnotobiotic mice harboring HBM. 18, 19 In the current work, we explored further the effects of single probiotics and prebiotics, and their combination (synbiotics), on the metabolic status of germfree mice during the establishment of the simplified HBM microbiota. To assess the underlying molecular mechanisms, we applied metabonomics to monitor the metabolism of major mammalian organs in combination with systemic biofluids, namely plasma, liver, urine, fecal extracts, pancreas, kidney cortex and medulla, adrenal gland extracts, cecal SCFAs, and ileal bile acids ( Figure 1 ). This multicompartmental approach provides a way forward to assess the metabolic impact of dietary modulations of the gut microbiota at a panorganismal scale, i.e. at the level of every major biological compartment. Moreover, it helps the assessment of key functional relationships among various biological compartments, intercompartment metabolic contributions to overall host metabolism, and the identification of changes in interorgan cross-talk in relation to nutritional interventions.
Material and Methods
Animal Handling. This study was conducted under the appropriate national guidelines at the Nestlé Research Center (Lausanne, Switzerland). A total of 39 C3H female germfree mice (Charles River, France) were housed under the same environmental conditions and were fed with a standard semisynthetic irradiated rodent diet. 20 At 8 weeks of age, the germfree mice received a single dose of human baby microbiota (HBM) bacteria mixture and were assigned randomly to 4 groups which followed different nutritional interventions over a 2 week period. Therefore, HBM was established simultaneously with the supplementations. One group was kept as control and was fed with a "basal mix" diet containing in composition 2.5% of a glucose-lactose mix (1.25% each) and received a saline drink ad libitum containing Man, Rogosa and Sharpe (MRS) culture medium (n ) 9). A second group of mice was given daily Lactobacillus rhamnosus (NCC4007) at 10 8 bacteria in MRS per day mixed with the ad libitum saline solution and was fed with the "basal mix" diet (probiotic intervention, n ) 10). A third group of mice was fed with a diet containing 3 g per 100 g diet of an in-house preparation of galacto-oligosaccharides and received an ad libitum saline drink containing MRS culture medium (prebiotic intervention, n ) 10). A fourth group was given daily the Lactobacillus rhamnosus at 10 8 bacteria in MRS per day mixed with the ad libitum saline solution and was fed with the diet supplemented in prebiotics (synbiotic intervention, n ) 10). Animals receiving L. rhamnosus were grouped together in the same isolator to avoid cross-contaminations with other groups.
The in-house preparation of prebiotics is composed of 80% commercially available galactosyl-oligosaccharides (Vivinal-GOS, Borculo Domo Ingredients, The Netherlands) 21 and 20% of a mixture containing other galactosyl-oligosaccharide structures 19 (Supporting Information). The control diet was supplemented with lactose and glucose to control for the lactose and glucose that were brought into the experimental diets by the used galactosyl-oligosaccharide preparations.
The preparation of the HBM was previously described 18 (Supporting Information). A total of 7 bacteria were isolated, namely Escherichia coli, Bifidobacterium breve and Bifidobacterium longum, Staphylococcus epidermidis and Staphylococcus aureus, Clostridium perfringens, and Bacteroides distasonis, and they were mixed in equal amounts (approximatively 10 10 cells/ mL for each strain) for gavage. Bacterial cell mixtures were kept in frozen aliquots until use. Lactobacillus rhamnosus NCC4007, obtained from the Nestlé Culture Collection (Lausanne, Switzerland), was grown in MRS, concentrated and resuspended in fresh MRS to 4 × 10 9 CFU/mL. Aliquots of 1 mL were frozen, and each day, a fresh defrosted aliquot was introduced in the isolator and mixed with the saline drinking water.
Sample Collection. Two fecal pellets were collected in sterile conditions for microbial profiling and NMR spectroscopy. Morning spot urines were also sampled separately. Animals were weighed and then euthanized. Blood (400 µL) was collected into Li-heparin tubes and the plasma was obtained after centrifugation. Samples were frozen at -80°C for NMR spectroscopy. The gastrointestinal tract from the duodenum to the cecum was removed from each animal. The cecal content was collected upon animal autopsy and snap-frozen immediately. The upper jejunum was retrieved in 10 mL sterile tubes containing 1 mL of glycerol for microbial profiling. Ileal flush samples were obtained by rinsing the ileal lumen with 1 mL of a phosphate buffer solution (0.2 M Na 2 HPO 4 /0.04 M NaH 2 PO 4 , pH ) 7.4). A section of liver was sampled in the same lobe for each animal and snap-frozen. The pancreas and the two adrenal glands were also collected and snap-frozen for NMR spectroscopy. The kidneys were also dissected, and the cortex was separated from the medulla before being snapfrozen. Fluid and tissue samples were maintained at -80°C prior to analysis.
Microbial Profiling of Fecal and Jejunal Contents and Bacterial Metabolic Activity. For fecal and jejunal samples, the bacterial populations for HBM and probiotics were determined using the conventional plating techniques reported previously 19 and described in the Supporting Information. Because bacterial populations were measured from the inoculation to euthanasia, the dilutions were defined at the beginning and kept constant throughout the study. However, the levels of certain bacteria dropped below the estimated range at the end of the study and the actual counts could not be obtained. Hence, we chose to use the less quantitative measures already given.
Total RNA was extracted from feces using a DNA/RNA Extraction kit (Qiagen, Switzerland). RNA integrity was assessed by electrophoresis of each sample in a 1.2% agarose gel that was stained with ethidium bromide solution and viewed by UV transillumination. RNA was quantified using the Ribogreen RNA Quantitation Reagent and Kit (Molecular Probes, Switzerland). Amplification of total bacterial community RNA was carried out by targeting 16S rRNA gene sequences with universal bacterial primers HDA1-GC and HDA-2 using the Qiagen
OneStep RT-PCR kit (Qiagen, Switzerland) and a program comprising one cycle of 30 min at 50°C (reverse transcription), one cycle of 15 min at 95°C, and then 35 cycles of 30 s at 94°C
, 30 s at 56°C, and 45 s at 72°C. Fifty nanograms of RNA were used for each RT-PCR. The amplification products were checked by electrophoresis in a 2% agarose gel stained with ethidium bromide and viewed by UV transillumination prior to further analysis. Denaturing gradient gel electrophoresis (DGGE) was performed using a DCode apparatus (Bio-Rad, USA) and 6% polyacrylamide gels with a 30-55% gradient of 7 M urea and 40% (v/v) formamide that increased in the direction of electrophoresis. Electrophoretic runs were in TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA) at 130 V and 60°C for 275 min. An identification ladder was prepared by extracting RNA from the individual components of the HBM used for gavage and then by RT-PCR amplification using the same pair of primers and amplification kit. Gels were stained with ethidium bromide solution for 20 min, washed with deionized water for 20 min, and viewed by UV transillumination. The intensity of staining of selected fragments in RNA-DGGE gel profiles was compared to that of Escherichia coli (which was constant in each sample and was used as an internal standard) and were analyzed from gel images with GeneTools gel analysis software (Syngene, Synoptics Ltd.).
Short Chain Fatty Acids and Lactate Cecal Content. Lactate was directly measured using a enzymatic BioAnalysis test kit (Boehringer Mannheim, R-Biopharm, Germany) according to the instructions provided by the manufacturer. Short chain fatty acids (SCFAs), that is, acetate, propionate, iso-butyrate, nbutyrate, iso-valerate and n-valerate, were extracted and measured as described previously and are reported in the Supporting Information.
1 H NMR Spectroscopic Analysis. Urine samples were prepared into 1. A portion of the tissue (∼15 mg) was packed into a zirconium oxide (ZrO 2 ) 4 mm outer diameter rotor. Due to the limited size of the adrenal glands, tissue extracts were prepared from both glands following the methods previously described. 22 Tissue samples were ground in 1 mL of acetonitrile/water (1:1). The supernatant containing the aqueous phase was collected, freeze-dried and redissolved in 60 µL of D 2 O. Samples were spun for 10 min at 6000g, and 50 µL of the supernatant was then pipetted into 1.7 mm NMR tubes.
1 H NMR spectra were acquired for each sample using a Bruker DRX 600 NMR spectrometer (Bruker Biospin, Rheinstetten, Germany) operating at 600.13 MHz for 1 H observation. 1 H NMR spectra of plasma, urine, and extracts of adrenal gland and feces were acquired with a Bruker 5 mm TXI triple resonance probe at 298 K.
1 H NMR spectra of intact tissues of liver, pancreas, kidney cortex and medulla were acquired using a standard Bruker high resolution MAS probe under magicangle-spinning conditions at a spin rate of 5000 Hz. 22 Tissue samples were regulated at 283 K using cold N 2 gas to minimize any time-dependent biochemical degradation.
For all of the samples, a NMR spectrum was acquired using a standard one-dimensional pulse sequence with water suppression. In addition, for intact tissues and plasma samples, Carr-Purcell-Meiboom-Gill (CPMG) spin-echo spectra with water suppression were obtained.
1 H NMR spectra were acquired and processed according to the parameters previously published 18 and given in the Supporting Information. UPLC-MS Material and Methods. Ultra Performance liquid chromatography (UPLC) of ileal flushes was performed on a ACQUITY UPLC system (Waters, Milford, MA) equipped with a Tof LCT-Premier (Waters MS Technologies, Manchester, UK) for mass detection using the method previously described 13 and is given in the Supporting Information.
Data Analysis. UPLC-MS data were processed using Micromass MarkerLynx Applications Manager Version 4.0 (Waters). The peaks of bile acids were identified by comparing the m/z ratio and retention time to the set of standard bile acids measured under the same conditions. Data were noise-reduced in both the UPLC and MS domains using a MarkerLynx standard routine. Integration of the UPLC-MS bile acid peaks was performed using ApexTrack2. Each peak integral was expressed as a percentage of the sum of integrals of the measured bile acids.
Statistical analysis of the changes in animal weights, bacterial populations, fecal composition in SCFAs and bile acid content in the feces and ileum was carried out using a two-tailed Mann-Whitney test.
The 1 H NMR spectra were digitized over the range of δ 0.2-10.0 using a Matlab script developed in-house (Imperial College London). The regions containing the water resonance (δ 4.5-5.2), and for urine spectra only the urea resonance (δ 4.5-6.2), were removed. The spectra were normalized to the sum of the spectrum prior to data analyses. O-PLS-DA of the NMR spectral data was carried out after applying scaling to unit variance. 23 The O-PLS-DA loading plots were processed according to the method described by Cloarec et al. 24 Here, the test for the significance of the Pearson product-moment correlation coefficient was used to calculate the cutoff value of the correlation coefficients at the level of p < 0.05. To test the validity of the model against overfitting, the cross-validation parameter Q 2 was computed and the standard 7-fold cross validation method was used. 24 The statistical total correlation spectroscopy (STOCSY) 25 method was also applied to spectral peaks found to be significantly different between different nutritional interventions in order to elucidate the structure of metabolites and to establish possible associations with other metabolic components.
Hepatic Triglycerides Quantitation. Hepatic triglycerides were extracted, following lyophilisation of liver tissues, using a Folch extraction procedure. 26 Total triglycerides were hydrolyzed using an enzymatic kit (TG PAP 150, Biomérieux, France), and total glycerol concentration was determined by colorimetry.
Taqman Real-Time Polymerase Chain Reaction (PCR) Analysis of Hepatic Microsomal Triglyceride Transfer Protein (MTTP) and Fatty Acid Synthase (FAS).
RNA extracted from frozen intact liver tissue was used for Taqman Real-Time PCR Analysis of MTTP and FAS. Briefly, RNA was extracted using TriPure Isolation Reagent (Roche, Switzerland) and purification with NucleoSpin RNA II kit (Macherey Nagel, Switzerland) according to the manufacturer's instructions. RNA purity and integrity were determined by RNA 6000 Nano LabChip Kit (Agilent Technologies, Switzerland). RNA quantification was achieved using RiboGreen RNA quantitation reagent kit. Total RNA from each sample was reverse transcribed with the first-strand cDNA synthesis kit for RT-PCR using ImProm-II Reverse Transcription System (Promega, Switzerland). TaqMan primers for MTTP and FAS (Applied Biosystems, Switzerland) were used together with Beta-2-microglobulin (B2M) as a house keeping gene. Real-time PCR amplification was performed using an ABI 7900HT Thermocycler (Applied Biosystems, Switzerland) with the following conditions: 2 min at 50°C and 10 min at 95°C for the initial setup, followed by 40 cycles at 95°C for 15 s (denaturation) and 60°C for 1 min (annealing and elongation). All samples were analyzed in triplicate. Relative gene expression was calculated after normalization to B2M.
Pixel Map Representation of the Intercompartments Metabolic Correlation. Correlation analysis was performed on normalized spectral intensities of metabolites discriminating the different groups according to nutritional intervention. To highlight major intra-and intercompartment metabolic correlations, the statistical analysis has been carried out only on metabolite extracts from urine, plasma, liver, pancreas and kidney cortex matrices. Pearson's correlation coefficients were generated when considering all the animals irrespectively of their group using a cutoff value of 0.5 for the absolute value of the coefficient |r|. Correlation coefficients above the cutoff are displayed using pixel maps. The value and the sign of the correlation were then color-coded (gradient of red colors for positive values, gradient of blue colors for negative values). The presence of colored pixels between specific metabolites reveals a correlation (above the cutoff) between these molecules that may reflect a functional association.
Results

Interventional Modulation of Transgenomic Metabolic
Interactions and Microbiome Composition. Microbial analyses were performed on mouse stools and jejunum luminal contents to assess the effects of the nutritional interventions on the gut bacterial ecology of HBM-associated mice (Table 1) . Daily consumption of L. rhamnosus resulted in increased colonization by B. longum in both the jejunum and feces compared to controls, and reduced fecal S. aureus populations. Prebiotic supplementation modified the intestinal microbial content with higher numbers of B. breve, B. longum and Bacteroides distasonis in both the jejunum and stools, while the E. coli and C. perfringens counts were decreased in the feces. Analysis of the samples obtained from HBM mice treated with the synbiotic mixture showed some effects on fecal microbiota that can be ascribed to additive or synergistic consequences of the single pro-and prebiotic intervention. The observed higher populations of B. breve, B. longum and lower numbers of C. perfringens were similar to those obtained when feeding the animals with prebiotics alone, while the reduction of S. aureus counts was similar to that induced with probiotics alone but of lower magnitude. The prebiotic-specific decrease in E. coli was not induced by the administration of synbiotic supplement. Denaturing gradient gel electrophoresis (DGGE) bands corresponding to E. coli, B. longum and C. perfringens showed appropriate resolution for analysis. For the 4 other strains, DGGE bands showed low intensity or were overlapped with each other (for Bacteroides distasonis and staphylococci). The ratio of the band intensity of B. longum and C. perfringens to that of E. coli was calculated, and expressed as relative metabolic activity. Results were reported as medians in each group of mice together with the bacterial counts ( Figure 2) . The values for the groups receiving nutritional intervention were compared to the control HBM animals using a median Fisher-exact-test. Relative metabolic activity of C. perfringens was reduced by the prebiotic prior to the reduction of bacterial counts. The presence of probiotic or synbiotic had no significant effect on the relative metabolic activity of C. perfringens as compared to the controls. Comparing counts and relative metabolic activity of B. longum revealed an increased metabolic activity of B. longum in the synbiotic group as compared to the prebiotic group, although counts were equal between the two groups, and in the controls. These results indicate that while the overall colonization by B. longum is similar between the prebiotics alone and synbiotic fed animals, there is an increase in metabolic activity in the latter. In addition, statistical comparison of the individual animal body weights did not reveal any significant differences related to the different treatments (Table S1 , Supporting Information). H spin-echo NMR spectra of plasma, intact liver, pancreas and kidney cortex tissues, and 1 H NMR spectra of adrenal glands, fecal extracts and urine from a HBM mouse supplemented with synbiotics are shown in Figure 3 . Assignments of metabolites are given in Table 2 and discussed in the Supporting Information.
Mutlicompartmental Metabolic Phenotyping and
The metabolic changes in response to intervention were evaluated statistically using a series of O-PLS-DA models 23 to compare the 1 H NMR profiles of each treatment group with the control group, that is, using a series of pairwise comparisons. A statistically significant separation between controls and mice supplemented with pro-, pre-and synbiotics was observed for each biological matrix (blood plasma, urine, fecal extract, liver, pancreas, kidney cortex and medulla, and adrenal extract) as reflected by the high value of Q Y 2 , but no significant metabolic changes were observed in the pancreas of HBM mice supplemented with L. rhamnosus compared to the untreated HBM mice (Table 3 ). The major metabolites that contributed to group separation are given as area normalized intensities (means ( SD) in Table 3 . Typical O-PLS-DA coefficients plots are presented for the pairwise comparison between HBM controls and HBM animals supplemented with the synbiotics Represented are control HBM group (HBM, black, n ) 9), group with prebiotics (HBM + prebiotic, blue, n ) 10), group with L. rhamnosus probiotics (HBM + L. rhamnosus, grey, n ) 10), and group with synbiotics L. rhamnosus in combination with prebiotics (HBM + L. rhamnosus + prebiotic, orange, n ) 10). The values for the groups receiving nutritional intervention were compared to the control HBM animals. ** and *** designate significant differences at 99% and 99.9% confidence levels, respectively. research articles
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in Figure 4 using back-scaling projection transformation. 24 The direction of the signals in the plots relative to zero indicates positive or negative covariance with the treated class compared to the controls. Each variable is color-coded according to its discriminating power as calculated from the correlation matrix, with variables highly influential in the discrimination highlighted in red (Figure 4) . Plasma Metabotypes. HBM mice fed with L. rhamnosus were distinguished from control HBM by significantly lower levels of plasma lipoproteins and choline (Table 3 ). Blood plasma of mice fed with the prebiotic showed a downward trend in glucose and increased levels of trimethylamine-N-oxide (TMAO), trimethylamine (TMA) and choline (Table 3) . Mice supplemented with the synbiotic showed relative decreases in plasma lipoproteins and citrate, and relative increases in TMAO and TMA ( Figure 4, Table 3 ).
Urinary Metabotypes. HBM mice receiving L. rhamnosus showed higher urinary excretion of R-keto-isovalerate and an 1 H NMR spectrum of adrenal glands extract (E), fecal extract (F) and urine (G) from a HBM mouse supplemented with synbiotics. The plasma regions δ 5.2-5.9 and 5.9-8.5 were magnified 2 and 6 times, respectively, compared to the aliphatic region (δ 0.7-4.5). The liver regions δ 5.2-5.8 and 5.8-10 were magnified 2 and 4 times, respectively. The pancreas and kidney cortex regions δ 5.18-9.0 were magnified 8 times. The spectra of the adrenal glands and fecal extracts were magnified 4 and 2 times, respectively, in the aromatic region (δ 5.2-8.5/9). The urine region 6.1-9.5 was magnified 4 times compared to the aliphatic region (δ 0.7-4.5). Key is given in Table 2 . upward trend in TMA levels, and lower levels of butyrate and isovalerate compared to controls (Table 3) . Prebiotic supplementation affected the urinary metabolic profiles of HBM mice manifested by increased concentrations of carnitine, acetylcarnitine, taurine, and decreased concentrations of R-ketoisocaproate, butyrate, lysine, and R-aminoadipate (Table 3 ). The synbiotic supplementation caused similar changes to those observed with prebiotic alone with an additional increase in excretion of creatine and R-keto-isovalerate compared to controls ( Figure 4 , Table 3 ). Fecal Metabotypes. Feeding HBM mice with L. rhamnosus resulted in higher fecal concentrations in several amino acids, including, valine, isoleucine, leucine, alanine, lysine, methionine, glutamine, glutamate, aspartate, asparagine, glycine, tyrosine, phenylalanine, tryptophan, and lactic acid (Table 3) . Prebiotic supplementation showed marked effects on the metabolic profiles of fecal extracts of HBM mice that included relative increased concentrations in choline, acetate, glycine, oligosaccharides, and reduced levels of glucose and fatty acids (Table 3) . Synbiotic supplementation induced increases in several amino acids, i.e. valine, leucine, isoleucine, alanine, glutamine, glutamate, glycine and choline, oligosaccharides, and decreased fecal fatty acids and glucose ( Figure 4, Table 3 ).
Hepatic Metabotypes. The livers of mice fed with L. rhamnosus showed relative decreases in glycogen and fumarate (Table 3) , whereas prebiotic supplemented mice showed relative decreases in hepatic triglycerides and relative increases in succinate, sarcosine, dimethylglycine (DMG), TMAO, betaine, choline, phosphocholine (PC), glucose, and alanine when compared to controls ( Table 3 ). The metabolites that differentiated the liver of mice fed with synbiotics from control animals included a trend in decreased lipid and relative increases in succinate, sarcosine, DMG, TMA, dimethylamine (DMA), TMAO, betaine, choline, PC, and alanine ( Figure 4, Table 3 ).
Pancreatic Metabotypes. Prebiotics and synbiotics affected the pancreas metabolic phenotypes of HBM mice, whereas probiotics alone did not induce statistically significant variations. The prebiotics-induced changes included increased levels of creatine, PC, TMAO, betaine and reduced levels of lactate, glycine and cysteine (Table 3) . Consumption of synbiotics was correlated with relative higher levels of sarcosine, DMG, creatine, PC, TMAO, betaine and decreased concentrations of lactate, cysteine and threonine ( Figure 4 , Table 3 ).
Renal Cortical Metabotypes. HBM mice receiving L. rhamnosus showed increased concentrations of glutamine, lysine and TMA, and reduced levels of lipids and lactate in kidney cortex (Table 3) . Consumption of prebiotics was correlated with a higher level of glutamine, and reduced concentrations of lipids compared to controls (Table 3) . Feeding HBM mice with synbiotics led to increased concentrations of alanine, lysine, glutamine, glutamate, glycine, methionine, TMA and PC, and reduced concentrations of lipids and lactate ( Figure 4 , Table  3 ).
Renal Medullary Metabotypes. Probiotic supplementation induced changes in the kidney medulla as noted with a reduced level of hypotaurine and higher levels of alanine and TMAO compared to controls (Table 3) . Feeding HBM mice with the prebiotic was correlated with a higher concentration of alanine and a reduced level of myo-inositol (Table 3) . HBM mice that received synbiotic supplementation showed increased concentrations in alanine, glutamine and TMAO, and a lower level of hypotaurine ( Figure 4, Table 3 ).
Adrenal Metabotypes. Adrenal glands obtained from HBM mice fed with L. rhamnosus showed higher levels of choline, glycerol, glycerate and decreases in ascorbate, aspartate, and asparagine (Table 3 ). Mice supplemented with the prebiotic showed increases in alanine, choline, glycerol, and glycerate and decreased ascorbate and aspartate (Table 3 ). The metabolites that differentiated mice fed with the synbiotic included increased alanine, glycerol, glycerate, choline, and decreased aspartate, asparagine and ascorbate ( Figure 4 , Table 3 ).
Cecal Short Chain Fatty Acids and Chiral Analysis of D/L Lactate. Significant reduction of lactate concentration was observed when feeding the HBM mice with the synbiotic mixture but not with other treatments (Table 4 ). The effect of the treatments on the cecal SCFA content is more complex. The acetate:propionate ratio was slightly decreased only in the probiotic treatment group (Table 4) . Isobutyrate levels were unaffected by any treatments but n-butyrate was reduced by the probiotic treatment and further reduced by the prebiotic administration, while coadministration did not result in any synergistic enhancements of changes. For isovalerate, the probiotic, the prebiotic and the synbiotic supplementations caused a similar increase. n-Valerate was reduced by the prebiotic supplement and the synbiotic treatment induced the same changes as the prebiotic.
UPLC-MS Analysis of Bile Acid Metabolites in Ileal
Flushes. The proportion of bile acids in ileal flushes from the different groups is given as mean ( SD of the percentage of the total bile acid content of each biological matrix (Table 5) . Taurochenodeoxycholic acid (TCDCA) was reduced in prebiotic and synbiotic supplemented mice but not in mice receiving the probiotic. The synbiotic treatment had less effect than prebiotics alone as observed with small reductions in tauroursodeoxycholic acid (TUDCA) in prebiotic treated mice. Moreover, the ileal profiles of probiotic supplemented mice showed a decrease in tauro-beta-muricholic acid (T MCA) and an increase in taurocholic acid (TCA).
Intra-and Intercompartmental Metabolite Correlation Analysis. To summarize and highlight major intra-and intercompartmental metabolic correlations suggested by pairwise statistical analyses, a correlation analysis was performed to identify any latent metabolic links between urine, plasma, liver, pancreas and kidney cortex biological matrices ( Figure 5A ). Such analyses were generated when considering all the animals irrespectively of their group. Noticeably, these analyses highlighted the strong correlation between metabolites involved in choline, methylamine, betaine and homocysteine metabolism. choline, PC, betaine, DMG, sarcosine, but also glucose and glycogen. Moreover, correlation analysis indicated that the levels of kidney lipids are negatively correlated with liver concentrations in DMG, DMA and sarcosine, pancreas levels of TMAO and betaine, kidney cortex content in TMA, PC, glutamine and lysine.
Discussion
Application of multicompartmental metabolic profiling here demonstrates the extent of the functional relationship between gut microbiome modulation and the metabolite composition of 10 biological matrices that link to host metabolic health. The metabolic effects of L. rhamnosus given alone or as synbiotics to germfree mice simultaneously colonized with HBM were similar to those previously observed in gnotobiotic mice harboring HBM. 19 Our data also suggest that major mammalian metabolic processes are under gut symbiont homeostatic control, and that galactosyl-oligosaccharides supplementation alone or as synbiotics might have profound implications for maintenance of metabolic health.
Prebiotic Modulation of Gut Microbiota. Complementary to our previous studies on probiotics and synbiotics, 18, 19 we assessed the effects of single prebiotic intervention in HBM mice. Galactosyl-oligosaccharides increased the populations of B. breve and B. longum, which are reported to digest galactosyloligosaccharides through specific -galactosidases. [31] [32] [33] In particular, Bifidobacteria have shown a high capacity to metabolize dietary oligosaccharides into large quantities of SCFAs, 34 as observed here with increased levels of acetate in the feces. Moreover, the acidification of the luminal environment resulting of the fermentation of carbohydrates by bifidobacteria may contribute to the reduced C. perfringens and E. coli populations. 33, 35 However, the marked reduction of the cecal butyrate content with prebiotics correlates with the reduction of C. perfringens, which is a primary butyrate producer.
Prebiotic Nutritional Intervention Links to Different Hepatic and Pancreatic Betaine-Homocysteine Metabolism. We observed altered transmethylation metabolic pathways that closely interconnect phosphocholine, betaine, dimethylgycine, sarcosine, choline, betaine and the formation of methionine from homocysteine, 36 in liver and pancreas. As a methyl donor, betaine is catabolized to dimethylglycine via the enzyme betaine-homocysteine-methyltransferase (BHMT), primarily in the liver and kidneys, and secondarily in the pancreas as summarized in Figure 5 -B. 37, 38 The coupled conversion of homocysteine to methionine is crucial for maintaining methionine homeostasis, detoxifying homocysteine, and producing S-adenosylmethionine. 37 The relative increased concentrations of hepatic and pancreatic phosphocholine, betaine, dimethylgycine, sarcosine and choline in the liver suggested higher betaine synthesis from choline and stimulated transmethylation in the methionine cycle, as evidenced in the pancreas by the observed reduced levels of cysteine. This hypothesis is in agreement with reports of compensatory changes between these metabolic pathways. 36, 38, 39 Moreover, betaine homocysteine metabolism is directly involved in the synthesis of phospholipids and carnitine. 37, 40 Higher urinary excretions of carnitine and acetyl-carnitine bring additional evidence of a stimulation of these biochemical processes. 41, 42 Prebiotic Supplementation Induced a Different Lipid Metabolism in Liver and Kidney. Our metabonomic analyses revealed that prebiotics alone induced a significant reduction of lipids in the liver compared to controls, whereas no alterations of blood plasma lipoproteins were observed. Likely, these hepatic changes are in triglycerides, which are the major source of lipids in the liver. Dietary oligosaccharides may reduce hepatic lipids through a modulation of hepatic lipogenic enzyme activities, postprandial insulinemia and glycemia. 43 We have here measured the concentration of triglycerides, and the gene expression of microsomal triglyceride transfer protein (MTTP) and fatty acid synthase (FAS) in the liver of controls and mice supplemented with prebiotics. Our results confirmed that galactosyl-oligossachrides decreased hepatic triglycerides, a metabolic event associated with decreased lipogenesis (reduced FAS expression) and reduced incorporation of triacylglycerols into nascent lipoprotein particles (reduced MTTP expression) ( Figure 6 ). Metabonomic analysis of kidney tissues revealed an additional reduction of its content in lipids. The kidney contributes to lipid metabolism through the uptake and -oxidation of long-chain fatty acids from the blood stream, 44 the uptake of protein-bound lipids and its ability to express apolipoproteins. 45 Therefore, the observed multiorgan metabolic changes showed the importance of galactosyl-oligosaccharides in modulating system lipid metabolism. Comparison of the concentrations of triglycerides in the liver of HBM controls (n ) 9) and HBM mice supplemented with prebiotics (n ) 9) displayed using box-and-whisker plots. Groups were compared using unpaired Student's t-test and the difference was statistical significant at 95% confidence level. Comparison of the expression of (B) microsomal triglyceride transfer protein (MTTP) and (C) fatty acid synthase (FAS) in the liver of HBM controls (n ) 9) and HBM mice supplemented with prebiotics (n ) 9). Differences between the groups are displayed using box-and-whisker plots. The decrease in expression levels in HBM + prebiotics animals was significant at 99.9% confidence level when using unpaired Student's t-test. Key: Delta CT is the difference between the threshold cycle of the gene of interest and that of the endogeneous reference gene.
The implications of our findings on lipid synthesis, circulation, and deposition must be investigated further in relation with the betaine-homocysteine metabolism. Indeed, increased BHMT metabolism is a potential mechanism contributing to higher ApoB secretion available for VLDL assembly. 46 Previous studies show complex carbohydrate diets result in higher secretion of nascent VLDL particles, smaller in size and carrying less triacylglycerols, and increased VLDL apo B fractional catabolic rates. 47 Therefore, our observation of enhanced BHMT metabolism and lower MTTP expression indicates higher apo B apoproteins synthesis and decreased transfer of lipids into nascent lipoproteins, which suggests the involvement of a similar mechanism in response to prebiotic interventions. Our observation may be of importance with the discovery that homocysteine may play a role in insulin release mechanism and pancreatic -cell function in diabetes. 48 Recently, prebiotic stimulation of bifidobacteria was also correlated with improved glucose tolerance and glucose-induced insulin secretion. 49, 50 Probiotic Supplementation Modulates Gut Microbial Mammalian Cometabolism. In the current experiment, L. rhamnosus supplementation resulted in a specific increased population of B. longum and decreased counts of S. aureus, as previously observed. 18 Multicompartmental metabonomics revealed that probiotic metabolic effects were also reproducible in this design of experiment, as noted with reduced plasma lipoproteins and hepatic levels of glutamine and glycogen. 18 The novel application of metabonomics to monitor adrenal gland metabolic variations revealed a correlated reduction in its content of ascorbate. The adrenal gland is among the organs with the highest concentration of ascorbate in the body, a crucial cofactor for catecholamine biosynthesis, antioxidation and adrenal steroidogenesis. 51, 52 Since ascorbate is crucial to the control of adrenal catecholamine levels, the observed changes in lipoproteins and gluconeogenetic pathways may be associated to the gut microbial modulation of the adrenal pool of ascorbate. 53 Further work is needed to decipher the mechanism of action of probiotics and their functional implications. Synbiotic-Specific Host and Bacterial Cometabolism. Overall, synbiotic nutritional intervention resulted in complementary effects of pro-and prebiotics, at both bacterial and host metabolic levels (Tables 1, 3 and 4) . However, the combination of galactosyl-oligosaccharides and L. rhamnosus induced a more significant bifidobacteria growth, and increased B. longum metabolic activity (Figure 2 ). The ability of B. longum to utilize galacto-oligosaccharides extensively 54, 55 is dependent on the pattern of glycosidic linkages and thus on the existence of specific -galactosidases. 56 Our observations suggest a synergistic interaction whereby L. rhamnosus may extend the B. longum metabolic capacities to degrade oligosaccharides. However, synbiotic supplementation had minimal effects on bacterial production of SCFAs in the cecum (Table 4 ) and the feces (Table 3 ) when compared to prebiotics alone. At the level of host cell pathways, synbiotic supplementation reduced levels of plasma lipoproteins, hepatic triglycerides and kidney lipids. Our analyses revealed that prebiotics alone induced a more significant reduction of triglycerides in the liver compared to synbiotics, and this was uncorrelated with changes in plasma lipoproteins. Collectively, these data indicate that probiotic and prebiotic modulations of gut microbiota affect different regulatory mechanisms of host energy and lipid metabolism at the level of absorption, mobilization and recirculation.
Conclusion
These studies exemplify the application of top-down systems biology 57 to capture the long-range effects of the gut microbiota modulation in various tissues and to assess the depth of symbiotic control in complex organisms. The nutritionally induced microbial changes modulated host lipid, carbohydrate and amino acid metabolism at a panorganismal scale. Altogether, our data highlight the contribution of microbial activity to dietary calorie recovery and to tightly regulate dietary fat absorption on one hand, lipid synthesis, circulation/recirculation and utilization by the host on the other hand. The observation that dietary modulations of gut microbial activity may lead to differential homocysteine or ascorbate metabolism, with inferred effects on glucose metabolism, insulin sensitivity, antioxidation or steroidogenesis is of particular interest. These studies suggest that major mammalian metabolic processes and interorgan cross-talks are strongly connected to the microbial activity, which in turn may have long-term health consequences to the host. In particular, our results further suggest that the gut microbiota should be a nutritional target for future interventions aiming to modulate host carbohydrate and lipid metabolism. Therefore, the integration of both individual metabolic predisposition and latent gut microbial metabolic contribution to the host will provide a future basis to develop optimized nutritional management.
Abbreviations: CFU, colony forming unit; GC, gas chromatography; HBM, human baby microbiota; ND, not detected; NMR, nuclear magnetic resonance; O-PLS-DA, orthogonal projection to latent structure discriminant analysis; PCA, principal component analysis; SD, standard deviation; SCFA, short chain fatty acid; STOCSY, statistical total correlation spectroscopy; TMA, trimethylamine, TMAO; trimethylamine-N-oxide.
